Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2023

Unravelling choices for adjuvant endocrine therapy in HR+ early breast cancer

ER positive breast cancer: What endocrine therapy is needed in menopausal patients?

Date

21 Oct 2023

Session

Unravelling choices for adjuvant endocrine therapy in HR+ early breast cancer

Topics

Tumour Site

Breast Cancer

Presenters

Patrick Neven

Authors

P. Neven

Author affiliations

  • Dept.gynaecological Oncology/multidisciplinary Breast Center, University Hospitals Leuven - Campus Gasthuisberg, 3000 - Leuven/BE

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Risk assessment stratification

Presenter: Nadia Harbeck

Session: Unravelling choices for adjuvant endocrine therapy in HR+ early breast cancer

Resources:

Slides

Webcast

Beyond chemo and endocrine therapy

Presenter: Stephen Johnston

Session: Unravelling choices for adjuvant endocrine therapy in HR+ early breast cancer

Resources:

Slides

Webcast

Q&A and Discussion

Presenter: All Speakers

Session: Unravelling choices for adjuvant endocrine therapy in HR+ early breast cancer

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.